Brain pharmacokinetics of two BBB penetrating bispecific antibodies of different size
Abstract Background Transferrin receptor (TfR1) mediated enhanced brain delivery of antibodies have been studied extensively in preclinical settings. However, the brain pharmacokinetics, i.e. brain entry, distribution and elimination are still not fully understood for this class of antibodies. The o...
Main Authors: | Rebecca Faresjö, Gillian Bonvicini, Xiaotian T. Fang, Ximena Aguilar, Dag Sehlin, Stina Syvänen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-06-01
|
Series: | Fluids and Barriers of the CNS |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12987-021-00257-0 |
Similar Items
-
Age, dose, and binding to TfR on blood cells influence brain delivery of a TfR-transported antibody
by: Rebecca Faresjö, et al.
Published: (2023-05-01) -
Brain pharmacokinetics of mono- and bispecific amyloid-β antibodies in wild-type and Alzheimer’s disease mice measured by high cut-off microdialysis
by: Ulrika Julku, et al.
Published: (2022-12-01) -
Reduction of αSYN Pathology in a Mouse Model of PD Using a Brain-Penetrating Bispecific Antibody
by: Sahar Roshanbin, et al.
Published: (2022-07-01) -
ImmunoPET imaging of amyloid-beta in a rat model of Alzheimer’s disease with a bispecific, brain-penetrating fusion protein
by: Gillian Bonvicini, et al.
Published: (2022-12-01) -
Enhanced anti-angiogenetic effect of transferrin receptor-mediated delivery of VEGF-trap in a glioblastoma mouse model
by: Peng Zhao, et al.
Published: (2022-12-01)